On Tuesday, the top TSX mover was Bombardier Inc. (TSX: T.BBD.B, Stock Forum). The stock lost 2% and was trading at $4.60 on volume of 5.3 million.
Today, the transportation equipment manufacturer announced that Seattle-based Horizon Air had signed a firm contract to acquire three 76-seat Bombardier Q400 NextGen turboprop airliners. The transaction represents the conversion of three previously booked options on the aircraft. The airline also reconfirmed its options on another seven Q400 NextGen aircraft.
Based on the list price of the Q400 NextGen aircraft, the contract announced today is valued at approximately $98 million US.
Orbite Aluminae Inc. (TSX: T.ORT, Stock Forum) was the second most active stock on the TSX. It soared % and was trading at $ on volume of million shares.
Today, the alumina producer announced an off-take agreement with Glencore International AG, a subsidiary of Glencore Xstrata plc, a multinational commodity trading and mining company, for the purchase of smelter-grade alumina from the corporation's proposed smelter-grade alumina (SGA) plant in Quebec, Canada.
Madalena Ventures Inc. (TSX: V.MVN, Stock Forum) was the volume leader on the TSX Venture Exchange. It gained 1.6% and was trading at $0.32 on volume of 1.3 million.
After the bell on June 17, the upstream oil and gas company announced it had retained a financial advisor to conduct joint venture partnering process on the Curamhuele Block.
On June 11, the oil and gas company said that the Province of Neuquén in Argentina had extended the exploration period for the Curamhuele block, in the Neuquén Basin of Argentina, by one year or until Nov. 8, 2014.
The second most active stock on the TSX Venture was Thallion Pharmaceuticals Inc. (TSX: V.TLN, Stock Forum). It rose 34.6% and was trading at $0.175 after 965 thousand shares changed hands.
Today, the biotechnology company announced that BELLUS Health has agreed to acquire Thallion for approximately $6.332 million in cash, or $0.1765 per share and the issuance of contingent value rights, which will entitle the holders thereof to additional payments of up to approximately $7.66 million, or $0.2135 per contingent value rights, if certain product revenue milestones are achieved and a future receivable is collected.